Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium:a meta-analysis
Author:
Clc Number:

R779.6

  • Article
  • | |
  • Metrics
  • |
  • Reference [20]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM:To evaluate the recurrence rate and safety of amniotic membrane transplantation (AMT) augmented with mitomycin C (MMC) compared with amniotic membrane transplantation alone during the pterygium excision. ·METHODS:We took a meta-analysis on this program. Pertinent studies were selected through extensive searches of the Cochrane Library,MEDLINE,EMBASE,CBMdisc,CNKI. Pooled estimates were carried out in RevMan software V4.2. ·RESULTS:Six trials reported postoperative recurrence rate of pterygium,included 882 eyes,three trials reported the complications. The results of meta-analysis showed that recurrence rate of AMT plus MMC group was 5.41%,AMT alone group was 16.89%,relative risk(RR) was 0.32,95%CI ranged from 0.19 to 0.56,Z was 4.06,P<0.001. Two trials reported early complication as punctata keratitis,the incidence rate of AMT plus MMC group and AMT alone group were 17.14% and 0.00%,RR was 12.11,95%CI ranged from 1.62 to 90.76. ·CONCLUSION:Amniotic membrane transplantation with MMC is associated with lower recurrence rate compared with amniotic membrane transplantation alone in pterygium excision,whether accompanied a higher risk with adverse events need more investigation.

    Reference
    1 West S, Muoz B. Prevalence of pterygium in Latinos: Proyecto VER.Br J Ophthalmol 2009;93(10):1287-1290
    2 Shiroma H, Higa A, Sawaguchi S, Iwase A, Tomidokoro A, Amano S, Araie M. Prevalence and risk factors of pterygium in a southwestern island of Japan: The Kumejiama Study. Am J Ophthalmol 2009;148(5):766-771
    3 Srinivasan S, Dollin M, McAllum P, Berger Y, Rootman DS, Slomovic AR. Fibrin glue versus for attaching the conjunctival autograft in pterygium surgery: a prospective observer masked clinical triall. Br J Ophthalmol 2009;93(2):215-218
    4 Hirst LW: The treatment of pterygium. Surv Ophthalmol 2003;48(2):145-180
    5 Majmudar PA, Epstein RJ. Antimetabolites in ocular surface neoplasia. Curr Opin Ophthalmol 1998;9(4):35-39
    6 Enock ME, Omoti AE, Dawodu OA, Fuh UC, Eguaoje IE. Effectiveness of intra-operative mitomycin C in reducing the recurrence of pterygium in Irrua, Nigeria. Niger Postgrad Med J 2010;17(1):55-59
    7 Essex RW, Snibson GR, Daniell M, Tole DM. Amniotic membrane grafting in the surgical management of primary pterygium. Clin Experiment Ophthalmol 2004;32(5):501-504
    8 Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 2005;24(2):141-150
    9 Tao T, Duan ZG, Yang CJ, Yu LY, Li MZ. Observation of amniotic membrane transplantation combined with mitomycin C to prevent pterygium recurrence. Chin J Ocular Trauma Occup Eye Di (Chin) s 2008;30(6):500-501
    10 Li SZ. Effect analysis of amnion membrane transplantation combined with mitomycin C in the treatment of pterygium. J Bethune Military Medical College (Chin)2007;10(5):290-291
    11 Gao EQ, Jin M. Effect analysis of frozen amnion membrane transplantation combined with mitomycin C in the treatment of pterygium. Guangzhou Med J (Chin) 2004;35(5):50-51
    12 Shi CN, Zhou GL. Application of mitomycin C in amniotic membrane transplantation to treat recurrence pterygium. Guangzhou Med J(Chin) 2006;37(5):37-39
    13 Chen XQ, Chen FX, Lai JW. Clinical study on mitomycin C combined with amniotic membrane transplantation in the treatment of pterygium. Chin J Difficult Complicat Cases(Chin) 2007;6(7):412-414
    14 Efstathios TD, Demetrios AS. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trend and perspectives. Int J Mol Med 2009;23:439-447
    15 Irit B, Igor K, Alex PL, Alana S, Eliya L, Wiwan S, Allan RS. The effect of mitomycin C on corneal endothelium in pterygium surgery. Am J Ophthalmol 2009;147(3):447-452
    16 Hirst LW,Sebban A,Chant D.Pterygium recurrence time. Ophthalmology 1994;101(4):755-758
    17 Avisar R, Apel I, Avisar I, Weinberger D. Endothelial cell loss during pterygium surgery: importance of timing of mitomycin C application. Cornea 2009;28(8):879-881
    18 Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99(11):1647-1654
    19 Dìaz L, Villegas VM, Emanuelli A, Izquierdo NJ. Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. Cornea 2008;27(10):1119-1121
    20 Wan Norliza WM, Raihan IS, Azwa JA, Ibrahim M. Scleral melting 16 years after pterygium excision with topical mitomycin C adjuvant therapy. Cont Lens Anterior Eye 2006;29(4):165-167
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yin-Wei Song, Ai-Hua Yu, Xiao-Jun Cai. ,/et al.Effectiveness of amniotic membrane transplantation combined with mitomycin C in the treatment of pterygium:a meta-analysis. Guoji Yanke Zazhi( Int Eye Sci) 2010;10(12):2238-2241

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History